<p><img src="https://images.cointelegraph.com/images/840_aHR0cHM6Ly9zMy5jb2ludGVsZWdyYXBoLmNvbS91cGxvYWRzLzIwMjQtMDcvMmQzYTNkMjEtMTQ4MS00OTgwLWE5NWItZGY5NzRiNzE1OWQwLmpwZw==.jpg"></p><p>Core Scientific’s stock performance triggers mandatory conversion of $260 million in secured convertible notes due in 2029.</p>